1921
Volume 77, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Endosymbionic bacteria inside adult worms (causing river blindness) are necessary for female worm fertility. We evaluated whether rifampin and/or azithromycin used in a five-day course could kill In an open-label trial in Guatemala, 73 patients with 134 palpable onchocercal nodules were randomized into four treatment groups: rifampin, azithromycin, a combination of the two drugs, and controls (multivitamins). After five days of antibiotic treatment, all participants received a single dose of ivermectin on day 6. Nine months after treatment, the nodules were removed and the worms were examined. Skin snips to determine microfilariae were obtained at baseline and nine months. There were no significant differences between any of the treatment groups in the condition of the worms in the nodules, the presence of surface protein, or the number of microfilariae in skin. Short courses with these antibiotics will not clear from .

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2007.77.878
2007-11-01
2017-09-25
Loading full text...

Full text loading...

/deliver/fulltext/14761645/77/5/0770878.html?itemId=/content/journals/10.4269/ajtmh.2007.77.878&mimeType=html&fmt=ahah

References

  1. Boatin BA, Richards FO Jr, 2006. Control of onchocerciasis. Adv Parasitol 61 : 349–394.
  2. Hoerauf A, Buttner DW, Adjei O, Pearlman E, 2003. Onchocerciasis. BMJ 25 : 207–210.
  3. Alleman MM, Twum-Danso NA, Thylefors BI, 2006. The Mectizan®donation program—highlights from 2005. Filaria J 5 : 11.
  4. Dadzie KY, Neira M, Hopkins D, 2003. Final report of the conference on the eradicability of onchocerciasis. Filaria J 2 : 2–32.
  5. Alley WS, van Oortmarssen GJ, Boatin BA, Nagelkerke N, Plaisier AP, Remme J, Lazdins J, Borsboom G, Habbema JD, 2001. Macrofilaricides and onchocerciasis control, mathematical modeling of the prospects for elimination. BMC Public Health 1 : 12.
  6. Hopkins DR, Richards FO, Katabarwa M, 2005. Whither onchocerciasis control in Africa? Am J Trop Med Hyg 72 : 1–2.
  7. Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, Fleischer B, Buttner DW, 2000. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355 : 1242–1243.
  8. Taylor MJ, Hoerauf A, 2001. A new approach to the treatment of filariasis. Curr Opin Infect Dis 14 : 727–731.
  9. Hoerauf A, Mand S, Adjei O, Fleischer B, Buttner DW, 2001. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357 : 1415–1416.
  10. Hoerauf A, Mand S, Volkmann L, Buttner M, Marfo-Debrekyei Y, Taylor M, Adjei O, Buttner DW, 2003. Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect 5 : 261–273.
  11. Hoerauf A, Adjei O, Buttner DW, 2002. Antibiotics for the treatment of onchocerciasis and other filarial infections. Curr Opin Investig Drugs 3 : 533–537.
  12. Townson S, Hutton D, Siemienska J, Hollick L, Scanlon T, Tagboto SK, Taylor MJ, 2000. Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi. Ann Trop Med Parasitol 94 : 801–816.
  13. Volkmann L, Fischer K, Taylor M, Hoerauf A, 2003. Antibiotic therapy in murine filariasis (Litomosoides signodontis): comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability. Trop Med Int Health 8 : 392–401.
  14. 2007. Physicians’ Desk Reference. 61st edition. Montvale, NJ: Thomson PDR.
  15. Schulz-Key H, 1978. A simple technique to assess the total number of Onchocerca volvulus microfilariae in skin snips. Trop Med Parasitol 29 : 51–54.
  16. Plaisier AP, Alley ES, Boatin BA, van Oortmarssen GJ, Remme H, de Vlas SJ, Bonneux L, Habbema JD, 1995. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J Infect Dis 172 : 204–210.
  17. Remme JH, 2004. Research for control: the onchocerciasis experience. Trop Med Int Health 9 : 243–254.
  18. Duke BO, Zea-Flores G, Muñoz B, 1991. The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin. Trop Med Parasitol 42 : 175–180.
  19. Albiez EJ, Buttner DW, Duke BO, 1988. Diagnosis and extirpation of nodules in human onchocerciasis. Trop Med Parasitol 39 : 331–346.
  20. Duke BO, 1990. An improved method of examining adult Onchocerca volvulus worms. Trop Med Parasitol 41 : 25–28.
  21. Duke BO, Zea-Flores G, Gannon RT, 1990. On the reproductive activity of female Onchocerca volvulus. Trop Med Parasitol 41 : 387–402.
  22. Cedillos RA, Warren M, Jeffrey GM, 1978. Field evaluation of primaquine in the control of Plasmodium vivax. Am J Trop Med Hyg 27 : 466–472.
  23. Anonymous, 2006. Onchocerciasis (river blindness). Report from the fifteenth InterAmerican Conference on Onchocerciasis, Caracas, Venezuela. Wkly Epidemiol Rec 81 : 293–296.
  24. Cupp EW, Cupp MS, 2005. Impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. Am J Trop Med Hyg 73 : 1159–1161.
  25. World Health Organization, 2001. Certification of Elimination of Human Onchocerciasis: Criteria and Procedures, Guidelines. Geneva: World Health Organization. WHO/CDS/CPE/CEE/2001.18.b.
  26. Cupp EW, Duke BOL, Mackenzie CD, Guzman JR, Vieira JC, Mendez-Galvan J, Castro J, Richards F, Sauerbrey M, Dominguez A, Eversole RR, Cupp MS, 2004. The effects of long-term community level treatment with ivermectin (Mectizan) on adult Onchocerca volvulus in Latin America. Am J Trop Med Hyg 71 : 602–607.
  27. Newell JN, Baral SC, Pande SB, Barn DS, Mall P, 2006. Family member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet 367 : 903–939.
  28. Osei-Atweneboana MY, Eng JKL, Boakye DA, Gyapong JO, Prichard RK, 2007. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369 : 2021–2029.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2007.77.878
Loading
/content/journals/10.4269/ajtmh.2007.77.878
Loading

Data & Media loading...

  • Received : 20 Jul 2007
  • Accepted : 02 Aug 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error